CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 95 filers reported holding CONCERT PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $250,000 | -7.7% | 24,300 | -9.3% | 0.04% | 0.0% |
| Q3 2016 | $271,000 | -12.9% | 26,800 | -3.2% | 0.04% | -18.0% |
| Q2 2016 | $311,000 | -19.4% | 27,690 | -2.1% | 0.05% | +56.2% |
| Q1 2016 | $386,000 | -31.4% | 28,290 | -4.7% | 0.03% | -64.4% |
| Q4 2015 | $563,000 | -0.9% | 29,670 | -2.0% | 0.09% | 0.0% |
| Q3 2015 | $568,000 | +78.6% | 30,270 | +41.9% | 0.09% | +83.7% |
| Q2 2015 | $318,000 | – | 21,330 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 2,610 | $620,000,000 | 6.47% |
| Parkman Healthcare Partners LLC | 1,124,072 | $4,732,000 | 1.74% |
| Kynam Capital Management, LP | 1,000,000 | $4,210,000 | 1.08% |
| EAM Investors, LLC | 850,647 | $3,581,000 | 0.87% |
| BVF INC/IL | 3,629,000 | $15,278,000 | 0.74% |
| EAM Global Investors LLC | 388,730 | $1,637,000 | 0.40% |
| RA Capital Management | 3,307,203 | $13,923,000 | 0.37% |
| Nantahala Capital Management | 1,659,840 | $6,988,000 | 0.35% |
| AWM Investment Company, Inc. | 504,661 | $2,125,000 | 0.34% |
| INGALLS & SNYDER LLC | 1,411,153 | $5,941,000 | 0.31% |